TITLE

Industry funding declines

AUTHOR(S)
Kondro, Wayne
PUB. DATE
September 2010
SOURCE
CMAJ: Canadian Medical Association Journal;9/7/2010, Vol. 182 Issue 12, pE577
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the reduced expenditures of pharmaceutical companies for research and development (R&D), in which CMR International 's data reveal that the companies have reduced expenditures by 0.3%. in 2009.
ACCESSION #
54111015

 

Related Articles

  • The 'patent cliff' looms large for Big Pharma.  // Australian Journal of Pharmacy;Jan2010, Vol. 91 Issue 1076, p40 

    The article reports on the expiration of patents within the pharmaceutical industry. It states patent expiries within the industry intensifies from 2011 onwards that affects some of the biggest brands in the industry such as Pfizer Inc.'s Lipitor which will drive down revenue growth. It notes...

  • Getting pharmaceutical R&D back on target. Bunnage, Mark E // Nature Chemical Biology;Jun2011, Vol. 7 Issue 6, p335 

    In this article, the author discusses the financial crisis of the pharmaceutical industry wherein quality improvement of target opportunity for drug discovery is needed to transform the research and development (R&D) productivity. He mentions the rising costs of development and the curse of...

  • The Effect of Research and Development Costs on the Profitability of Pharmaceutical Companies. Hajiheydari, Abdellah; Dastgir, Mohsen; Soltani, Asghar // Interdisciplinary Journal of Contemporary Research in Business;Dec2011, Vol. 3 Issue 8, p914 

    The pharmaceutical industry is rapidly expanding and research and development undoubtedly are required to ensure its prosperity in international markets. Since the cost of research and development studies for large and multinational pharmaceutical companies is very high and sometimes reaches up...

  • China's Drug Addiction. Kingsbury, Kathleen // Time International (Atlantic Edition);11/26/2007, Vol. 170 Issue 21, p50 

    The article reports on the growth of the pharmaceutical industry in China. The author states that China is attracting international drug companies to do research and development by offering reduced costs for clinical trials in comparison with what it costs to do business in other countries. The...

  • China's Drug Addiction. Kingsbury, Kathleen // Time;11/26/2007, Vol. 170 Issue 22, p74 

    The article reports on the growth of the pharmaceutical industry in China. The author states that China is attracting international drug companies to do research and development by offering reduced costs for clinical trials in comparison with what it costs to do business in other countries. The...

  • Empirical study on pharmaceutical economic and investment in research and development based on correlation analysis. Sun Xiaojuan; Gai Huaqing // Journal of Chemical & Pharmaceutical Research;2014, Vol. 6 Issue 4, p670 

    The pharmaceutical industry has developed widely in recent years. And the relationship between the economic growth of pharmaceutical industry and the investment in research and development synchronization has been concerned. The application of correlation analysis on it is studied in depth....

  • Identifying R&D outliers. Tollman, Peter; Morieux, Yves; Murphy, Jeanine Kelly; Schulze, Ulrik // Nature Reviews Drug Discovery;Sep2011, Vol. 10 Issue 9, p653 

    The article focuses on companies and outliers which are more successful in counteracting the trend of declining productivity in research and development (R&D) in the pharmaceutical industry. It states that R&D expenditures of companies from 1998 to 2004 were compared with successful new...

  • DECODING THE ADAPTABILITY--RIGIDITY PUZZLE: EVIDENCE FROM PHARMACEUTICAL INCUMBENTS' PURSUIT OF GENE THERAPY AND MONOCLONAL ANTIBODIES. KAPOOR, RAHUL; KLUETER, THOMAS // Academy of Management Journal;2015, Vol. 58 Issue 4, p1180 

    The emergence of radical technologies presents a significant challenge to incumbent firms. We study firms' management of radical technological change by separating their actions into upstream research (the "R" of R&D) and downstream development (the "D" of R&D). We introduce two contingencies to...

  • Global Health Concerns Create Business Opportunities. Wechsler, Jill // Pharmaceutical Technology;Sep2009, Vol. 33 Issue 9, p26 

    The article reports on the business opportunities and the support for research and development (R&D) for new vaccines in the developing nations, as a result of the global concern on health. It notes the expansion of pharmaceutical industries in the emerging markets as exemplified by New...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics